These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

476 related items for PubMed ID: 31180332

  • 1. MORC2 promotes cell growth and metastasis in human cholangiocarcinoma and is negatively regulated by miR-186-5p.
    Liao G, Liu X, Wu D, Duan F, Xie X, Wen S, Li Y, Li S.
    Aging (Albany NY); 2019 Jun 09; 11(11):3639-3649. PubMed ID: 31180332
    [Abstract] [Full Text] [Related]

  • 2. Long non-coding RNA MIR22HG inhibits cell proliferation and migration in cholangiocarcinoma by negatively regulating the Wnt/β-catenin signaling pathway.
    Hu X, Tan Z, Yang Y, Yang P.
    J Gene Med; 2019 May 09; 21(5):e3085. PubMed ID: 30856284
    [Abstract] [Full Text] [Related]

  • 3. Akirin2 is modulated by miR-490-3p and facilitates angiogenesis in cholangiocarcinoma through the IL-6/STAT3/VEGFA signaling pathway.
    Leng K, Xu Y, Kang P, Qin W, Cai H, Wang H, Ji D, Jiang X, Li J, Li Z, Huang L, Zhong X, Sun X, Wang Z, Cui Y.
    Cell Death Dis; 2019 Mar 18; 10(4):262. PubMed ID: 30886152
    [Abstract] [Full Text] [Related]

  • 4. miR-378 serves as a prognostic biomarker in cholangiocarcinoma and promotes tumor proliferation, migration, and invasion.
    Zhou Z, Ma J.
    Cancer Biomark; 2019 Mar 18; 24(2):173-181. PubMed ID: 30594918
    [Abstract] [Full Text] [Related]

  • 5. Yin Yang 1-induced LINC00667 up-regulates pyruvate dehydrogenase kinase 1 to promote proliferation, migration and invasion of cholangiocarcinoma cells by sponging miR-200c-3p.
    Li J, Guan C, Hu Z, Liu L, Su Z, Kang P, Jiang X, Cui Y.
    Hum Cell; 2021 Jan 18; 34(1):187-200. PubMed ID: 33040228
    [Abstract] [Full Text] [Related]

  • 6. AR-induced ZEB1-AS1 represents poor prognosis in cholangiocarcinoma and facilitates tumor stemness, proliferation and invasion through mediating miR-133b/HOXB8.
    Jiang X, Li J, Wang W, Hu Z, Guan C, Zhao Y, Li W, Cui Y.
    Aging (Albany NY); 2020 Jan 24; 12(2):1237-1255. PubMed ID: 31978895
    [Abstract] [Full Text] [Related]

  • 7. Upregulated LASP-1 correlates with a malignant phenotype and its potential therapeutic role in human cholangiocarcinoma.
    Zhang H, Li Z, Chu B, Zhang F, Zhang Y, Ke F, Chen Y, Xu Y, Liu S, Zhao S, Liang H, Weng M, Wu X, Li M, Wu W, Quan Z, Liu Y, Zhang Y, Gong W.
    Tumour Biol; 2016 Jun 24; 37(6):8305-15. PubMed ID: 26729195
    [Abstract] [Full Text] [Related]

  • 8. MicroRNA-494-dependent WDHDI inhibition suppresses epithelial-mesenchymal transition, tumor growth and metastasis in cholangiocarcinoma.
    Liu B, Hu Y, Qin L, Peng XB, Huang YX.
    Dig Liver Dis; 2019 Mar 24; 51(3):397-411. PubMed ID: 30314946
    [Abstract] [Full Text] [Related]

  • 9. Circ-LAMP1 contributes to the growth and metastasis of cholangiocarcinoma via miR-556-5p and miR-567 mediated YY1 activation.
    Xu Y, Gao P, Wang Z, Su Z, Liao G, Han Y, Cui Y, Yao Y, Zhong X.
    J Cell Mol Med; 2021 Apr 24; 25(7):3226-3238. PubMed ID: 33675150
    [Abstract] [Full Text] [Related]

  • 10. E2F1-induced upregulation of long non-coding RNA LMCD1-AS1 facilitates cholangiocarcinoma cell progression by regulating miR-345-5p/COL6A3 pathway.
    Yu J, Zhang B, Zhang H, Qi Y, Wang Y, Wang W, Wang Y, Wang Y.
    Biochem Biophys Res Commun; 2019 Apr 30; 512(2):150-155. PubMed ID: 30876691
    [Abstract] [Full Text] [Related]

  • 11. Tetraspanin 1 promotes epithelial-to-mesenchymal transition and metastasis of cholangiocarcinoma via PI3K/AKT signaling.
    Wang Y, Liang Y, Yang G, Lan Y, Han J, Wang J, Yin D, Song R, Zheng T, Zhang S, Pan S, Liu X, Zhu M, Liu Y, Cui Y, Meng F, Zhang B, Liang S, Guo H, Liu Y, Hassan MK, Liu L.
    J Exp Clin Cancer Res; 2018 Dec 04; 37(1):300. PubMed ID: 30514341
    [Abstract] [Full Text] [Related]

  • 12. MicroRNA-329-mediated PTTG1 downregulation inactivates the MAPK signaling pathway to suppress cell proliferation and tumor growth in cholangiocarcinoma.
    Hu ZG, Zheng CW, Su HZ, Zeng YL, Lin CJ, Guo ZY, Zhong FD, Yuan GD, He SQ.
    J Cell Biochem; 2019 Jun 04; 120(6):9964-9978. PubMed ID: 30582202
    [Abstract] [Full Text] [Related]

  • 13. SP1-induced HOXD-AS1 promotes malignant progression of cholangiocarcinoma by regulating miR-520c-3p/MYCN.
    Li J, Jiang X, Li Z, Huang L, Ji D, Yu L, Zhou Y, Cui Y.
    Aging (Albany NY); 2020 Aug 28; 12(16):16304-16325. PubMed ID: 32857725
    [Abstract] [Full Text] [Related]

  • 14. MicroRNA-21 regulates biological behavior by inducing EMT in human cholangiocarcinoma.
    Liu Z, Jin ZY, Liu CH, Xie F, Lin XS, Huang Q.
    Int J Clin Exp Pathol; 2015 Aug 28; 8(5):4684-94. PubMed ID: 26191158
    [Abstract] [Full Text] [Related]

  • 15. YY1-induced DLEU1/miR-149-5p Promotes Malignant Biological Behavior of Cholangiocarcinoma through Upregulating YAP1/TEAD2/SOX2.
    Li J, Jiang X, Xu Y, Kang P, Huang P, Meng N, Wang H, Zheng W, Wang H, Wang Z, Zhong X, Cui Y.
    Int J Biol Sci; 2022 Aug 28; 18(11):4301-4315. PubMed ID: 35864972
    [Abstract] [Full Text] [Related]

  • 16. Sirtuin7 has an oncogenic potential via promoting the growth of cholangiocarcinoma cells.
    Li W, Sun Z, Chen C, Wang L, Geng Z, Tao J.
    Biomed Pharmacother; 2018 Apr 28; 100():257-266. PubMed ID: 29438839
    [Abstract] [Full Text] [Related]

  • 17. Up-regulation of ZFAS1 indicates dismal prognosis for cholangiocarcinoma and promotes proliferation and metastasis by modulating USF1 via miR-296-5p.
    Li Z, Jiang X, Huang L, Li J, Ji D, Xu Y, Leng K, Cui Y.
    J Cell Mol Med; 2019 Dec 28; 23(12):8258-8268. PubMed ID: 31565837
    [Abstract] [Full Text] [Related]

  • 18. LncRNA FALEC increases the proliferation, migration and drug resistance of cholangiocarcinoma through competitive regulation of miR-20a-5p/SHOC2 axis.
    Du H, Hou S, Zhang L, Liu C, Yu T, Zhang W.
    Aging (Albany NY); 2023 May 09; 15(9):3759-3770. PubMed ID: 37166421
    [Abstract] [Full Text] [Related]

  • 19. LINC00844 suppresses tumor progression and predicts survival outcomes through inhibiting miR-19a-5p in cholangiocarcinoma.
    Zhang L, Jiang G, Lu J, Wang L.
    Clin Transl Oncol; 2024 Feb 09; 26(2):414-423. PubMed ID: 37400667
    [Abstract] [Full Text] [Related]

  • 20. miR-181b-5p Promotes the Progression of Cholangiocarcinoma by Targeting PARK2 via PTEN/PI3K/AKT Signaling Pathway.
    Jiang ZL, Zhang FX, Zhan HL, Yang HJ, Zhang SY, Liu ZH, Jiang Y, Lv LZ, Ke RS.
    Biochem Genet; 2022 Feb 09; 60(1):223-240. PubMed ID: 34169384
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.